SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : OTC: Pink Sheet Stock Picking Challenge -- Ignore unavailable to you. Want to Upgrade?


To: WR61499 who wrote (4552)5/22/2008 12:23:03 AM
From: creede  Read Replies (1) | Respond to of 5455
 
re LBWR -

hey, WR61499, is it just me, or is this impressive?

sec.gov

G. Dexter Morris, CEO, President and Chairman. Mr. Morris has been our Chief Executive Officer, President and Chairman of the Board since the inception of the Company on October 8, 2004. Before founding Labwire, Mr. Morris served as CEO, President and Chairman of Drug Intervention Services of America (“DISA”) from 1987 to 2004, which was one of the industry’s premier Third Party Administrators, which Mr. Morris grew to seven (7) offices and over one hundred (100) employees nationwide. Mr. Morris has been involved in the drug testing industry since its inception. He was one of the five (5) founding Members of the Substance Abuse Program Administrators Association (“SAPAA”) in 1989, the drug testing industry’s trade and lobbying arm. Mr. Morris has developed a reputation as an expert on drug testing issues, including “the Drug Free Workplace Act of 1988”, the Department of Transportation (“D.O.T.”) drug testing regime [49 CFR, Part 40], and state regulation of drug testing. He has written various training and educational texts on drug testing and compliance and has served as spokesman for the industry both nationally and internationally. Mr. Morris is a pioneer in the development of non-DOT corporate drug testing policies and programs and the aggregation of workers data for large, disparate groups [consortia; oil & gas, contracting, etc.] utilizing data collection and analysis to enhance the cost-effectiveness of drug testing programs. He has recently served as the United States’ representative to the First International Symposium on Workplace Drug Testing in 2005 in Sao Paulo and Rio De Janeiro, Brazil, which began to set international standards and credentials for drug testing worldwide. Mr. Morris now voluntarily serves as the Chairman of the nonprofit International Organization for Drugfree Workplaces (“IODW”) and has spoken at many international conferences as many nations attempt to standardize drug testing rules allowing both multinational and local companies to reduce drug use in their workplaces. Mr. Morris graduated from Texas Tech University with a bachelor’s degree in Business Administration where he has participated in a visiting professor program for several years.

GB-ND-42
creede